BCM
ABBV icon

Barometer Capital Management’s AbbVie ABBV Stock Holding History

Barometer Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$3.92M – 135
2024
Q3 		$3.92M Buy
+20,000
New +$3.73M 1.13% 28
2018
Q1 		– Sell
-211,850
Closed -$20.5M – 131
2017
Q4 		$20.5M Buy
211,850
+3,950
+2% +$372K 1.85% 10
2017
Q3 		$18.5M Buy
+207,900
New +$15.8M 1.79% 13

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barometer Capital Management's ABBV Position: Q4 2024 in Review

Barometer Capital Management sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 20,000 shares — an estimated $3.92M sold.

Barometer Capital Management first reported a position in ABBV in Q3 2017 and held it in 3 quarters. The position peaked at $20.5M in Q4 2017. 3,750 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Barometer Capital Management reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Barometer Capital Management sold 20,000 AbbVie shares in Q4 2024, an estimated $3.92M.
  • Barometer Capital Management first reported a position in AbbVie in Q3 2017 and held it in 3 quarters.
  • Barometer Capital Management's AbbVie position peaked at $20.5M in Q4 2017.
  • 3,750 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Barometer Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.